Yu‐Li Su
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Chun‐Chieh Huang (24 shared papers)Hao‐Lun Luo (24 shared papers)Po‐Hui Chiang (13 shared papers)Kun‐Ming Rau (9 shared papers)Ming-Tse Sung (8 shared papers)Ming-Yen Tsai (5 shared papers)Yen‐Yang Chen (7 shared papers)Jei‐Ming Peng (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Frontiers in Oncology (6 papers)International Journal of Molecular Sciences (5 papers)Journal of Cancer (4 papers)PLoS ONE (3 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Yu‐Li Su
71 papers receiving 668 citations
Peers
Comparison fields: 5 of 81
- Oncology 186
- Cancer Research 82
- Surgery 191
- Pulmonary and Respiratory Medicine 127
- Hepatology 24
Countries citing papers authored by Yu‐Li Su
This map shows the geographic impact of Yu‐Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Li Su more than expected).
Fields of papers citing papers by Yu‐Li Su
This network shows the impact of papers produced by Yu‐Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Li Su. The network helps show where Yu‐Li Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 34 | |
| 2 | 2020 | 33 | |
| 3 | 2013 | 31 | |
| 4 | 2018 | 27 | |
| 5 | 2022 | 26 | |
| 6 | 2019 | 25 | |
| 7 | 2019 | 24 | |
| 8 | 2007 | 21 | |
| 9 | 2020 | 19 | |
| 10 | 2018 | 19 | |
| 11 | 2015 | 19 | |
| 12 | 2022 | 18 | |
| 13 | 2015 | 18 | |
| 14 | 2021 | 16 | |
| 15 | 2022 | 15 | |
| 16 | 2023 | 14 | |
| 17 | 2014 | 14 | |
| 18 | 2015 | 14 | |
| 19 | 2023 | 14 | |
| 20 | 2018 | 13 |
About Yu‐Li Su
Yu‐Li Su is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 78 papers that have together received 673 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (25 papers), Cancer Immunotherapy and Biomarkers (9 papers), Urinary and Genital Oncology Studies (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Renal cell carcinoma treatment (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (186 citations), Cancer Research (82 citations), Surgery (191 citations), Pulmonary and Respiratory Medicine (127 citations) and Hepatology (24 citations). Yu‐Li Su has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chun‐Chieh Huang, Hao‐Lun Luo, Po‐Hui Chiang, Kun‐Ming Rau, Ming-Tse Sung, Ming-Yen Tsai, Yen‐Yang Chen, Jei‐Ming Peng, Yung‐Hsiang Chen and Jen‐Jie Lin. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, International Journal of Molecular Sciences, Journal of Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.